XML 35 R18.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Earnings Per Share | 6 Months Ended
--- | ---
Jun. 30, 2017
Earnings Per Share [Abstract] |
Earnings Per Share | (13) Earnings Per Share For the three months ended June 30, 2017 and 2016, basic and diluted net income per share are calculated as follows:
|  | Three Months Ended June 30, |
|  | 2017 |  |  | 2016 |
Basic income per share |  |  |  |  |  |
Net income for the period - numerator |  | $ | 15,917 |  |  | $ | 2,581,606 |
Weighted average common stock outstanding - denominator |  |  | 21,450,316 |  |  |  | 21,450,316 |
Net income per share |  | $ | 0.00 |  |  | $ | 0.12 |
Diluted income per share |  |  |  |  |  |  |  |
Net income for the period- numerator |  | $ | 15,917 |  |  | $ | 2,581,606 |
Weighted average common stock outstanding - denominator |  |  | 21,450,316 |  |  |  | 21,450,316 |
Effect of dilution |  |  | - |  |  |  | - |
Weighted average common stock outstanding |  |  | 21,450,316 |  |  |  | 21,450,316 |
Diluted income per share |  | $ | 0.00 |  |  | $ | 0.12 |
For the six months ended June 30, 2017 and 2016, basic and diluted net income per share are calculated as follows:
|  | Six Months Ended |
|  | 2017 |  |  | 2016 |
Basic income per share |  |  |  |  |  |
Net income for the period - numerator |  | $ | 1,723,786 |  |  | $ | 1,207,709 |
Weighted average common stock outstanding - denominator |  |  | 21,450,316 |  |  |  | 21,381,404 |
Net income per share |  | $ | 0.08 |  |  | $ | 0.06 |
Diluted income per share |  |  |  |  |  |  |  |
Net income for the period - numerator |  | $ | 1,723,786 |  |  | $ | 1,207,709 |
Weighted average common stock outstanding - denominator |  |  | 21,450,316 |  |  |  | 21,381,404 |
Effect of dilution |  |  | - |  |  |  | - |
Weighted average common stock outstanding - denominator |  |  | 21,450,316 |  |  |  | 21,381,404 |
Diluted income per share |  | $ | 0.08 |  |  | $ | 0.06 |
For the three and six months ended June 30, 2017 and 2016, 820,312 warrants shares are excluded from the calculations of dilutive net income per share as their effects would have been anti-dilutive since the average share price were lower than the warrants exercise price. For the three and six months ended June 30, 2017, there were no securities with dilutive effect issued and outstanding.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration